Skip to main content
VCbacked
Log inGet Started

Ashvattha Therapeutics

Redwood City, United States

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.

$50.0M raised
Jan 2025
Series B
BiotechnologyHealth CarePharmaceuticalTherapeutics

Top Investors

Tribe CapitalEcoR1 CapitalPlum AlleySam AltmanModi Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ashvattha Therapeutics

How much funding has Ashvattha Therapeutics raised?
Ashvattha Therapeutics has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in January 2025.
Who are Ashvattha Therapeutics's investors?
Ashvattha Therapeutics's investors include Tribe Capital, EcoR1 Capital, Plum Alley, Sam Altman, Modi Ventures.
Where is Ashvattha Therapeutics headquartered?
Ashvattha Therapeutics is headquartered in Redwood City, United States.
What does Ashvattha Therapeutics do?
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.
What stage is Ashvattha Therapeutics at?
Ashvattha Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ashvattha Therapeutics — Funding & Investors." VCBacked, January 13, 2025, https://www.vcbacked.co/company/ashvattha-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2025). Ashvattha Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/ashvattha-therapeutics
Wikipedia (cite web)
{{cite web |title=Ashvattha Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ashvattha-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong